How IBD Stock Of The Day TG Therapeutics Is Catching Up To Roche, Novartis
TG Therapeutics is Tuesday's IBD Stock Of The Day. Shares topped a buy zone despite a mixed Q3 report, but are in range of an alternate entry.
The post How IBD Stock Of The Day TG Therapeutics Is Catching Up To Roche, Novartis appeared first on Investor's Business Daily .